BioNexus Gene Lab (BGLC) Stock: Buy, Sell, or Hold?

BGLC - BioNexus Gene Lab Corp Common stock

SERVICES-MEDICAL LABORATORIES
$1.19
0.00 (0.00%) ▲
5d: -2.54%
30d: -19.05%
90d: -22.73%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 13, 2026 20d

Get Alerted When BGLC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: BGLC shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: BGLC is currently trading at $1.19, which is considered oversold relative to its 30-day fair value range of $1.22 to $1.45.

Technical Outlook: Technically, BGLC is in a strong downtrend. The price is currently testing key support at $1.19. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: BGLC scores 76/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.22 - $1.45
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 94.1%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (76/100)
  • BULLISH: High volume confirmation
  • WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $1.22 - $1.45
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $1.19
Resistance Level $1.39
Current Trend Strong Downtrend
Technical data as of Oct 22, 2026

Fundamental Context

Revenue Growth (YoY) -96.6%
Earnings Growth (YoY) -95.0%
Profit Margin -82.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 22, 2026 11:05 PM ET
Data refreshes hourly during market hours. Next update: 12:05 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BGLC.

Create Free Account

Already have an account? Log In

Top Rated Specialty Chemicals Stocks

Top-rated stocks in Specialty Chemicals by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LIN
Linde plc Ordinary Shares
STRONG BUY
29 analysts
$544 41 HOLD
ECL
Ecolab Inc
STRONG BUY
24 analysts
$325 48 HOLD
SHW
Sherwin-Williams Co
BUY
29 analysts
$383 45 HOLD
DD
Dupont De Nemours Inc
STRONG BUY
18 analysts
$165 72 BUY
ALB
Albemarle Corp
BUY
23 analysts
$162 54 HOLD

More Analysis for BGLC

BGLC Technical Chart BGLC Price Prediction BGLC Earnings Date BGLC Investment Advisor BGLC Fair Price Analyzer BGLC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals